Laboratorios Farmaceuticos Rovi, S.A. Stock Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
19:39:14 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 57.58 EUR | -1.50% |
|
+1.83% | -7.66% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3B 3.44B 2.84B 2.58B 4.82B 330B 4.84B 33.81B 13.07B 168B 12.94B 12.65B 537B | P/E 2026 * |
19.8x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.99B 3.43B 2.83B 2.57B 4.8B 329B 4.83B 33.72B 13.04B 167B 12.9B 12.61B 535B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.28x |
| Free-Float |
31.63% | Yield 2026 * |
1.66% | Yield 2027 * | 1.98% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Tradegate
| 41L | Real-time | |
|
Berne S.E.
| 41L | End-of-day quote | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.09% | ||
| 1 week | +1.83% | ||
| Current month | -3.71% | ||
| 1 month | +1.12% | ||
| 3 months | -0.51% | ||
| 6 months | -26.94% | ||
| Current year | -7.66% |
| 1 week | 57.3 |  | 58.8 |
| 1 month | 57.3 | | 61.8 |
| Current year | 53.15 | | 86.6 |
| 1 year | 53.15 | | 86.6 |
| 3 years | 45.82 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | +1.83% | - | - | 3.44B | |
| -0.34% | +2.62% | +51.61% | +100.19% | 1,027B | |
| -0.85% | +1.45% | +52.49% | +67.37% | 651B | |
| -0.04% | +3.54% | +19.57% | +73.56% | 467B | |
| -0.51% | +4.91% | +38.09% | +39.99% | 350B | |
| -0.05% | +3.71% | +20.17% | +26.28% | 268B | |
| +0.59% | +6.75% | +11.11% | +16.50% | 257B | |
| +0.58% | -0.70% | +38.25% | +45.67% | 205B | |
| +0.28% | +2.79% | -27.61% | -56.31% | 190B | |
| +0.39% | +4.20% | +34.41% | +99.41% | 187B | |
| Average | +0.37% | +2.49% | +26.45% | +45.85% | 400.23B | |
| Weighted average by Cap. | +0.21% | +2.62% | +35.25% | +62.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 889M 733M 666M 1.24B 85.11B 1.25B 8.73B 3.37B 43.25B 3.34B 3.26B 138B | 892M 1.02B 845M 767M 1.43B 98.13B 1.44B 10.06B 3.89B 49.87B 3.85B 3.76B 160B |
| Net income | 146M 168M 138M 126M 235M 16.08B 236M 1.65B 637M 8.17B 631M 617M 26.16B | 173M 198M 164M 149M 278M 19.01B 279M 1.95B 754M 9.66B 746M 729M 30.93B |
| Net Debt | -8.5M -9.76M -8.04M -7.31M -13.65M -935M -13.72M -95.81M -37.05M -475M -36.66M -35.84M -1.52B | -72.51M -83.25M -68.62M -62.35M -116M -7.97B -117M -817M -316M -4.05B -313M -306M -12.97B |
| Date | Price | Change |
|---|---|---|
| 17/09/26 | €58.45 | 0.00% |
| 16/09/26 | €58.45 | +1.39% |
| 15/09/26 | €57.65 | -0.17% |
| 14/09/26 | €57.75 | +0.09% |
| 11/09/26 | €57.70 | +0.52% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
